Accelovance

read moreLinical is a public, midsized CRO headquartered in Japan with a significant presence across North America, Europe, and Asia-Pacific. Linical provides the full spectrum of drug development services from early stage to large-scale, multinational studies. Our areas of expertise include Phase I-IV oncology, infectious disease, and CNS research. Linical was established in June 2005 by a group of professionals who were engaged in new drug development at a major Japanese pharmaceutical company. Ever since, in accordance with our philosophy of contributing to new drug development and promoting the well-being of patients, we have supported the clinical development efforts of pharmaceutical companies, focusing mainly on areas for which new drug development is sorely needed.

read moreLinical operates three core service divisions; a full-service CRO, Pharmacovigilance, and a Patient Engagement Solutions group to positively impact the advancement of clinical research. As a clinical services provider to the pharmaceutical and biotech industries, Linical offers comprehensive services including management and implementation of Phase I-IV clinical trials, patient recruitment/retention solutions, and a Clinical Call Center that can assist in recruitment, retention, long-term follow-up, and post-marketing surveillance.